复合诱变选育林肯霉素高产菌株

以林肯链霉菌9502(Streptomyces lincolnensis9502)为出发菌株,进行NTG诱变处理,并用高效的琼脂块培养法对菌株进行筛选,得到产林肯霉素相对效价提高35.4%的变异株9502-7。对9502-7菌株孢子采用紫外线处理,得到变异高产菌株9502-7-12,其相对效价较出发菌株提高50%以上。     

常压室温等离子体(ARTP)诱变及高通量筛选那西肽高产菌株

采用新型常压室温等离子体(ARTP)诱变活跃链霉菌(Streptomyces actuosu),并应用抑菌圈和48孔板培养方法高通量筛选高产那西肽菌株。研究表明抑菌圈径的大小与48孔板效价之间以及48孔板效价与摇瓶效价之间均有较好的相关性,系数R分别达到0.534和0.896。通过多轮ARTP诱变及高通量筛选最终获得了3株相对效价提高50%以上的遗传性能稳定的突变株。ARTP诱变技术作为获得那西肽高产菌株的有效途径,与传统摇瓶发酵筛选相比,48孔板及抑菌圈法能显著提高那西肽高产菌株的筛选效率。     

通过获得链霉素抗性基因突变株筛选小诺霉素高产菌株

通过链霉素对小诺霉素产生菌 (Micromonospora purpura) 49 1 2 #菌株孢子致死浓度的测定 ,采用诱变剂EMS 3种不同诱变剂量对菌株的孢子进行诱变处理 ,诱变处理的孢子涂布在含链霉素致死浓度的改良高氏平板上 ,获得大量的链霉素抗性基因突变株 ,然后从链霉素抗性基因突变株进一步筛选小诺霉素高产菌株 ,获得小诺霉素菌株 49 1 2 3菌株。在摇瓶条件下 ,其产小诺霉素生物活性单位比出发菌株 49 1 2 #的摇瓶发酵单位提高了 40 %以上。小诺霉素的组分比由出发菌株的C2b∶C1a的 5∶5提高到 8∶2。C2b有效组分提高了 30 %;链霉素抗性基因突变与小诺霉素发酵单位突变之间 ,小诺霉素正突变率达到 40 %,负突变率达 2 6%,正突变大于负突变     

维吉霉素产生菌株X-435的诱变育种

链霉菌菌株x-435是从北京郊区采集的土样中分离得到的1株维吉霉素产生菌。为了提高维吉霉素的产量,采用紫外线对出发菌株x-435进行紫外线诱变处理,诱变处理后在高氏培养基上产生3种菌落形态,确定草帽型的菌落为阳性突变株的菌落形态,经过筛选获得效价高于出发菌株近20倍的突变株F5-25-u-28,且传代5代后稳定性较好。     

梅岭霉素产生菌抗药性突变标志诱变筛选模型的初步研究

本文通过梅岭霉素 (Meilingmycin)产生菌南昌链霉菌NS 4 1 80菌株孢子对 6种抗生素敏感性测定 ,采用诱变剂EMS四种不同诱变剂量对菌株孢子进行诱变处理 ,诱变处理的孢子涂布在含致死浓度链霉素的高氏平板上。然后从抗药性突变标志菌株中进一步筛选梅岭霉素高产菌株。在 150 0多个抗药性突变株中通过初筛获得了比诱变出发菌株的产素能力提高 50 %以上菌株。通过诱变剂量分别与抗药性突变率和突变株产素产量的变势统计分析表明 ,菌株抗药性突变与产素突变密切相关 ,产素突变的EMS诱变剂量高于抗药性突变诱变剂量 ,在 0 .0 3mol/LEMS剂量作用下 ,菌株致死率为 99.4 3% ,抗药性突变率为 0 .0 4 4 0 % ,建立了梅岭霉素产生菌抗药性突变标志诱变推理性筛选模型。为南昌链霉菌高产菌种选育研究作了有益的尝试 ,并有助于其它链霉菌属的抗生素产生菌育种研究。     

产类细菌素乳酸乳球菌V528的紫外线诱变育种研究

目的获取高产抑制鸡白痢沙门菌生长的类细菌素乳酸乳球菌的突变菌株。方法在紫外线照射致死率为82.7%的剂量下,对处于对数生长后期的乳酸乳球菌V528进行紫外线二次复合诱变处理。分别随机对第一次和第二次复合处理后生长的117株和310株菌进行效价测定分析。结果在实验所用的照射剂量下,抑菌效价提高的正突变菌株占有一定优势,负突变菌株较少,其中突变菌株Lact.174的抑菌效价较V528的效价提高了8.48倍,并具有一定的遗传稳定性。结论运用紫外诱变育种技术可有效地获得高产类细菌素的突变菌株。     

基因组重排与传统育种相结合选育大观霉素高产菌株

以壮观链霉菌(Streptomyces spectabilis)为研究对象,采用基因组重排技术与传统诱变育种相结合的方法选育大观霉素的高产菌株.通过原生质体紫外诱变获得壮观链霉菌突变体群体,高产突变菌株间进行两轮的基因组重排,筛选的高产菌株用NTG诱变得新霉素和链霉素的抗性突变菌株,抗性突变菌株间进行两轮基因组重排,从...     

高产不饱和油脂海鞘真菌桔青霉Asc-2-4的诱变选育

诱变育种是获得高产菌株,实现微生物工业化生产油脂的重要措施。以前期获得的高产不饱和油脂菌株桔青霉（Penicillium citrinum）Asc-2-4为出发菌株,利用丙二酸建立快速筛选高产不饱和脂肪酸突变菌的方法,通过紫外线 氯化锂复合诱变得到1株高产油脂突变菌Asc-2-4-1,油脂含量比出发菌株提高了92.98%。经过初步的培养基无机盐优化,其油脂得率和不饱和脂肪酸产量达到了7.10 g/L和3.84 g/L,与Asc-2-4相比,分别提高了84.42%和77.78%。结果表明,通过复合诱变选育技术可选育出高产突变菌株,选育的Asc-2-4-1可望作为产油微生物被开发利用。     

抗性突变他克莫司高产菌株的选育

研究利用核糖体工程育种方法结合紫外诱变处理产他克莫司链霉菌SIIA-9818,以期筛选得到发酵水平有较大提高的新菌株。首轮采用链霉素抗性筛选,第二轮组合链霉素和利福平抗性结合紫外诱变育种,进一步巩固育种成效。采用链霉素抗性诱变得到突变株T-122,其气生菌丝丰满程度明显好于原对照株,发酵效价提高22.8%;采用组合链霉素和利福平抗性结合紫外诱变T-122,得到多株高产菌株,其中H-493发酵水平较原出发菌株提高82.6%;在50 L发酵罐通过增大搅拌转速,使菌种H-493发酵单位进一步提高31.0%。本方法简单经济,得到的突变株发酵单位显著提高,组分无明显变化,传代稳定。     

等离子体-紫外复合诱变选育四羟基环孢菌素衍生物高产菌株

筛选可体内转化合成环孢菌素衍生物([γ-HyMeLeu4]CyA)的高产菌株。以稀有放线菌Nonomuraea dietziae为出发菌株,采用常温常压等离子体射流和紫外照射对其进行复合物理诱变。通过该诱变方法获得了具有稳定遗传性能的菌株,其转化效率比出发菌株提高了32%左右。结果表明,等离子体诱变可有效的用于该稀有放线菌,通过等离子体-紫外复合诱变筛选得到的突变菌株可用于工业生产。     

Enthalpy screen of drug candidates

The enthalpic and entropic contributions to the binding affinity of drug candidates have been acknowledged to be important determinants of the quality of a drug molecule. These quantities, usually summarized in the thermodynamic signature, provide a rapid assessment of the forces that drive the binding of a ligand. Having access to the thermodynamic signature in the early stages of the drug discovery process will provide critical information towards the selection of the best drug candidates for development. In this paper, the Enthalpy Screen technique is presented. The enthalpy screen allows fast and accurate determination of the binding enthalpy for hundreds of ligands. As such, it appears to be ideally suited to aid in the ranking of the hundreds of hits that are usually identified after standard high throughput screening.     

High-throughput-PCR screen of 15,000 transgenicPhyscomitrella plants

An easy-to-handle protocol was developed for the rapid screening of a large number ofPhyscomitrella plants. Genomic DNA was isolated without liquid nitrogen or mechanical disruption of plant material and subsequently screened by PCR. This protocol has been applied successfully to approximately 15,000 mutants (800–1000 plants per wk). About 90% of the plants could be identified as either transgenic or nontransgenic in a single PCR reaction. The results of the PCR-based identification were verified by an additional round of selection of mutants on antibiotic-containing medium.     

Inducible CRISPRa screen identifies putative enhancers

Enhancers are critical cis-regulatory elements that regulate spatiotemporal gene expression and control cell fates. However, the identification of enhancers in native cellular contexts still remains a challenge. Here, we develop an inducible CRISPR activation (CRISPRa) system by transgenic expression of doxycycline (Dox)-inducible dCas9-VPR in mouse embryonic stem cells (iVPR ESC). With this line, a simple introduction of specific guide RNAs targeting promoters or enhancers allows us to realize the effect of CRISPRa in an inducible, reversible, and Dox concentration-dependent manner. Taking advantage of this system, we induce tiled CRISPRa across genomic regions (105 kilobases) surrounding T (Brachyury), one of the key mesodermal development regulator genes. Moreover, we identify several CRISPRa-responsive elements with chromatin features of putative enhancers, including a region the homologous sequence in which humans harbors a body height risk variant. Genetic deletion of this region in ESC does affect subsequent T gene activation and osteogenic differentiation. Therefore, our inducible CRISPRa ESC line provides a convenient platform for high-throughput screens of putative enhancers.